- Home
- CAC vs CRMD Comparison
CAC vs CRMD Comparison
Compare CAC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CAC | CRMD |
|---|---|---|
| Founded | 1875 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 680.5M | 943.9M |
| IPO Year | 1997 | 2010 |
Fundamental Metrics
Financial Performance| Metric | CAC | CRMD |
|---|---|---|
| Price | $44.70 | $12.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $47.33 | $17.43 |
| AVG Volume (30 Days) | 86.1K | ★ 2.6M |
| Earning Date | 01-27-2026 | 11-12-2025 |
| Dividend Yield | ★ 3.75% | N/A |
| EPS Growth | ★ 9.13 | N/A |
| EPS | ★ 3.49 | 2.25 |
| Revenue | ★ $215,172,000.00 | $214,303,672.00 |
| Revenue This Year | $44.50 | $627.89 |
| Revenue Next Year | $7.03 | $40.95 |
| P/E Ratio | $12.82 | ★ $5.41 |
| Revenue Growth | 27.50 | ★ 1647.67 |
| 52 Week Low | $34.53 | $5.60 |
| 52 Week High | $46.80 | $17.43 |
Technical Indicators
Market Signals| Indicator | CAC | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.36 | 63.25 |
| Support Level | $43.60 | $11.78 |
| Resistance Level | $46.80 | $12.51 |
| Average True Range (ATR) | 1.07 | 0.49 |
| MACD | -0.09 | 0.11 |
| Stochastic Oscillator | 62.73 | 82.48 |
Price Performance
Historical ComparisonAbout CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.